EYEG - EyeGate Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts0122
Avg. Estimate0-0.43-2.17-1.35
Low Estimate0-0.43-2.67-1.63
High Estimate0-0.43-1.68-1.08
Year Ago EPS-0.750.15-2.23-2.17
Revenue EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts0122
Avg. EstimateN/AN/A50k5.5M
Low EstimateN/AN/AN/A3M
High EstimateN/AN/A100k8M
Year Ago SalesN/AN/A2.69M50k
Sales Growth (year/est)N/AN/A-98.10%10,900.00%
Earnings History12/30/20183/30/20196/29/201912/30/2019
EPS Est.-0.9-0.75-0.75-0.81
EPS Actual-0.750.15-0.6-0.71
Difference0.150.90.150.1
Surprise %16.70%120.00%20.00%12.30%
EPS TrendCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Current Estimate0-0.43-2.17-1.35
7 Days Ago00-2.67-1.63
30 Days Ago00-2.67-1.63
60 Days Ago00-2.67-1.63
90 Days Ago00-2.67-1.63
EPS RevisionsCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesEYEGIndustrySectorS&P 500
Current Qtr.N/AN/AN/A-0.45
Next Qtr.-386.70%N/AN/A-0.16
Current Year2.70%N/AN/A-0.23
Next Year37.80%N/AN/A0.31
Next 5 Years (per annum)N/AN/AN/A0.04
Past 5 Years (per annum)N/AN/AN/AN/A